Magnetic resonance lymphangiography with a nano-sized gadolinium-labeled dendrimer in small and large animal models

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Sharma R, Wendt JA, Rasmussen JC, Adams KE, Marshall MV, Sevick-Muraca EM: New horizons for imaging lymphatic function. Ann. NY Acad. Sci.1131,13–36 (2008).
  Medline CASGoogle Scholar
• 2  Barrett T, Choyke PL, Kobayashi H: Imaging of the lymphatic system: new horizons. Contrast Media Mol. Imaging1(6),230–245 (2006).▪ Excellent review article on the basis and application of lymphatic imaging.
  Medline CASGoogle Scholar
• 3  Kobayashi H, Kawamoto S, Sakai Y et al.: Lymphatic drainage imaging of breast cancer in mice by micro-magnetic resonance lymphangiography using a nano-size paramagnetic contrast agent. J. Natl Cancer Inst.96(9),703–708 (2004).
  Medline CASGoogle Scholar
• 4  Kobayashi H, Kawamoto S, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW: Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. Cancer Res.63(2),271–276 (2003).▪ First paper describing lymphatic MRI using a dendrimer-based contrast agent.
  Medline CASGoogle Scholar
• 5  Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A, Jordan VC: Early breast cancer. Lancet373(9673),1463–1479 (2009).
  MedlineGoogle Scholar
• 6  Nair SK, Petko M, Hayward MP: Aetiology and management of chylothorax in adults. Eur. J. Cardiothorac. Surg.32(2),362–369 (2007).
  MedlineGoogle Scholar
• 7  Cha EM, Sirijintakarn P: Anatomic variation of the thoracic duct and visualization of mediastinal lymph nodes: a lymphographic study. Radiology119(1),45–48 (1976).
  Medline CASGoogle Scholar
• 8  McGrath EE, Blades Z, Anderson PB: Chylothorax: aetiology, diagnosis and therapeutic options. Respir. Med.104(1),1–8 (2010).
  MedlineGoogle Scholar
• 9  Alomari AI, Karian VE, Lord DJ, Padua HM, Burrows PE: Percutaneous sclerotherapy for lymphatic malformations: a retrospective analysis of patient-evaluated improvement. J. Vasc. Interv. Radiol.17(10),1639–1648 (2006).
  MedlineGoogle Scholar
• 10  Burrows PE, Mitri RK, Alomari A et al.: Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat. Res. Biol.6(3–4),209–216 (2008).
  Medline CASGoogle Scholar
• 11  Mine S, Udagawa H, Kinoshita Y, Makuuchi R: Post-esophagectomy chylous leakage from a duplicated left-sided thoracic duct ligated successfully with left-sided video-assisted thoracoscopic surgery. Interact. Cardiovasc. Thorac Surg.7(6),1186–1188 (2008).
  MedlineGoogle Scholar
• 12  Hoshida T, Isaka N, Hagendoorn J et al.: Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-c increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res.66(16),8065–8075 (2006).
  Medline CASGoogle Scholar
• 13  Kakinuma T, Nadiminti H, Lonsdorf AS et al.: Small numbers of residual tumor cells at the site of primary inoculation are critical for anti-tumor immunity following challenge at a secondary location. Cancer Immunol. Immunother.56(7),1119–1131 (2007).▪▪ Describes the efficacy of lymphatic MRI for detecting lymphadema.
  MedlineGoogle Scholar
• 14  McElroy M, Hayashi K, Garmy-Susini B et al.: Fluorescent LYVE-1 antibody to image dynamically lymphatic trafficking of cancer cells in vivo. J. Surg. Res.151(1),68–73 (2009).
  Medline CASGoogle Scholar
• 15  Kobayashi H, Kawamoto S, Bernardo M, Brechbiel MW, Knopp MV, Choyke PL: Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging. J. Control. Release111(3),343–351 (2006).
  Medline CASGoogle Scholar
• 16  Kobayashi H, Kawamoto S, Choyke PL et al.: Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography. Magn. Reson. Med.50(4),758–766 (2003).
  Medline CASGoogle Scholar
• 17  Kobayashi H, Brechbiel MW: Nano-sized MRI contrast agents with dendrimer cores. Adv. Drug Deliv. Rev.57(15),2271–2286 (2005).▪ Excellent review describing synthesis, application and experimental details for MRI contrast agents based on gadolinium-dendrimers.
  Medline CASGoogle Scholar
• 18  Longmire M, Choyke PL, Kobayashi H: Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine3(5),703–717 (2008).
  CASGoogle Scholar
• 19  Xu H, Regino CA, Bernardo M et al.: Toward improved syntheses of dendrimer-based magnetic resonance imaging contrast agents: new bifunctional diethylenetriaminepentaacetic acid ligands and nonaqueous conjugation chemistry. J. Med. Chem.50(14),3185–3193 (2007).▪▪ Describes a new chemical conjugation method, which was used in this study.
  Medline CASGoogle Scholar
• 20  Hama Y, Bernardo M, Regino CA et al.: MR lymphangiography using dendrimer-based contrast agents: a comparison at 1.5t and 3.0t. Magn. Reson. Med.57(2),431–436 (2007).
  MedlineGoogle Scholar
• 21  Wiener EC, Brechbiel MW, Brothers H et al.: Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn. Reson. Med.31(1),1–8 (1994).▪▪ First paper to describe a dendrimer-based MRI contrast agent.
  Medline CASGoogle Scholar
• 22  Konda SD, Aref M, Wang S, Brechbiel M, Wiener EC: Specific targeting of folate-dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magma12(2–3),104–113 (2001).
  Medline CASGoogle Scholar
• 101  MRI Analysis Calculator www.rsb.info.nih.gov/ij/plugins/mri-analysis.html
  Google Scholar
• 102  ImageJ http://rsb.info.nih.gov/ij/
  Google Scholar